Icon

RELYVRIO (NDA216660)- (3GM/PACKET; 1GM/PACKET)

SODIUM PHENYLBUTYRATE; TAURURSODIOL AMYLYX
3GM/PACKET; 1GM/PACKET
No No
2040-Jul-27 2027-Sep-29
None None
None No
RELYVRIO is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
3GM/PACKET; 1GM/PACKET ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.